Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06385249
Other study ID # NAV-0012
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date April 3, 2024
Est. completion date December 2024

Study information

Verified date April 2024
Source Wellspect HealthCare
Contact Peter Wide, MD
Phone +46 010-1031341
Email Peter.Wide@regionostergotland.se
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The study is designed to deliver further information on clinical benefit, patients' satisfaction, and perception of handling and to confirm safety of Navina Mini when used in children and adolescents.


Description:

This is an uncontrolled, prospective, multicentre post-market clinical follow-up investigation that will enroll male and female children /adolescents with a need for low-volume transanal irrigation (TAI) as judged by the investigator or designee. A total of 27 subjects in need of low-volume TAI will be recruited from 2-3 sites in Sweden and will be treated with Navina Mini as per product intended purpose and per instruction of use. Participating subjects will perform three visits during the clinical investigation and will be followed for a total of four (4) to six (6) weeks. The study is designed to deliver further information on clinical benefit, patients' satisfaction, and perception of handling and to confirm device safety when used in children and adolescents.


Recruitment information / eligibility

Status Recruiting
Enrollment 27
Est. completion date December 2024
Est. primary completion date October 2024
Accepts healthy volunteers No
Gender All
Age group 3 Years to 17 Years
Eligibility Inclusion Criteria: - Signed informed consent - Male and female children/adolescents between 3 and 17 years of age at the time of inclusion - Diagnosis of at least one of the following: - functional constipation not well treated with oral laxatives - functional fecal incontinence, either retentive or non-retentive (FNRFI: Functional Non-Retentive Fecal Incontinence) not well treated with oral laxatives - neurogenic bowel dysfunction due to spinal abnormalities and/or spinal cord injury or cerebral palsy - patient with sequelae of anorectal malformations to Hirschsprung disease - Fecal Incontinence (FI) due to iatrogenic injury including tumor surgery sequelae - Symptom duration of > 3 months - Subject and/or their legally designated representative can communicate in written and oral Swedish language Exclusion Criteria: - Children/adolescents previously treated with, or currently in need of, high volume TAI, i.e., volume > 250 ml - Confirmed pregnancy at the time of enrollment - Participating in another clinical investigation interfering with this investigation - Subjects with an active, symptomatic, inflammatory bowel disease, radiation proctitis, and or active perianal fistula disease - Rectal bleeding of uncertain origin or active hemorrhoidal bleeding - < 6 months after anal or colorectal surgery - Ongoing anti-coagulant therapy (i.e., NOACS, heparin, warfarin) - Ischemic colitis - Active anal fissure - Inability to use the product or anyone to assist in its usage (hand function assessment) - Person not suitable for the investigation according to the investigator's judgment

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Navina Mini
Trans-anal irrigation (TAI) with a new CE-marked device, Navina Mini

Locations

Country Name City State
Sweden H.K.H. Kronprinsessan Victorias Barn- och ungdomssjukhus Universitetssjukhuset Linköping

Sponsors (1)

Lead Sponsor Collaborator
Wellspect HealthCare

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary Overall patient satisfaction Overall patient satisfaction measured with a 5-graded assessment scale (Patient Reported Outcome (PRO) via Wellspect Questionnaire: 0 = Not at all satisfied, 1 = Not satisfied, 2 = Neither satisfied nor unsatisfied, 3=Satisfied, 4 = Very satisfied) up to 6 weeks
Secondary Incomplete bowel emptying Subjects' perception of incomplete bowel emptying measured with a 4-graded assessment scale (PRO via Wellspect Questionnaire: 0 = Never, 1= Seldom, 2= Often, 3= Always) up to 6 weeks
Secondary Episodes of fecal incontinence Episodes of obstructed defecation outlet syndrome or episodes of fecal incontinence as documented in a diary on a daily basis up to 6 weeks
Secondary Level of independence Patients population able to use the device themselves: need support during the whole procedure, need support in parts of the procedure, no support needed: Yes and No answers up to 6 weeks
Secondary Perception of handling of the device Subjects' perception of handling of the device measured with a 5-graded assessment scale (PRO via Wellspect Questionnaire: Evaluation of Navina Mini (0 = Very difficult, 1 = Difficult, 2 = Neither difficult nor easy, 3= Easy, 4 = Very easy) or (0 = Strongly disagree, 1 = Agree, 2 = Neither agree nor disagree, 3 = Agree, 4 = Strongly agree)) up to 6 weeks
Secondary Safety outcome Assessment of adverse events and device deficiencies up to 6 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT04205058 - Coffee After Pancreatic Surgery N/A
Recruiting NCT05380856 - Sacral Neuromodulation for Neurogenic Lower Urinary Tract, Bowel and Sexual Dysfunction N/A
Completed NCT00135577 - Study 767905/008 Extension Study: Alvimopan for Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects Phase 2
Completed NCT03028636 - LIBERATE - PRO: Eclipseâ„¢ System Registry
Completed NCT05880446 - PROstate CAncer Radiotherapy - Bowel Quality of Life (PROCAR-BQ) N/A
Active, not recruiting NCT06311110 - Impaired Toilet Training, LUTS and Bowel Dysfunction in Children With DCD
Not yet recruiting NCT04507945 - Stablishment of Prevention and Treatment System for Intestinal Dysfunction Phase 1/Phase 2
Completed NCT00101998 - Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication Phase 2
Recruiting NCT05716230 - Bowel Function and Associated Risk Factors for Bowel Dysfunciton in Patients With Anorectal Malformation
Completed NCT05644912 - Exploratory Investigation on a Novel Catheter N/A
Recruiting NCT04319991 - The Clinical Evaluation of Probiotics Product in Patients With Various Functional Bowel Disorders and Helicobacter Pylori Infection N/A
Completed NCT03885999 - Studies in Patients With Low Anterior Resection Syndrome (LARS) N/A
Active, not recruiting NCT04546672 - Sugammadex To IMprove Bowel Function Phase 4
Not yet recruiting NCT06252714 - Impact of Defecation Posture on Ease of Bowel Movements in Patients With a Rectocele N/A
Recruiting NCT04914975 - The Effect of NMES on Bowel Management in People With Chronic SCI N/A
Active, not recruiting NCT04490642 - Linguistic Validation of the Childhood Bladder and Bowel Dysfunction Questionnaire (CBBDQ) for 5-12 Years Old in Korean
Completed NCT04299867 - Perioperative Tissue Penetration of Antimicrobials in Infants
Recruiting NCT06288464 - Enteral Feeding of Fibre to Improve Microbiota N/A
Completed NCT05351138 - Comparison of Transcutaneous Electrical Nerve Stimulation and Manual Therapy in Children With Cerebral Palsy N/A
Completed NCT03841513 - Minimally Invasive Burch Colposuspension to Reduce Occult Stress Incontinence N/A